A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy–induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial

Background. Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) are associated with bone loss leading to increased fracture rate among HIV-infected individuals. ART-induced bone loss is most intense within the first 48 weeks of therapy, providing a window for prophylaxis wi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Infect Dis
Glavni autori: Ofotokun, Ighovwerha, Titanji, Kehmia, Lahiri, Cecile D., Vunnava, Aswani, Foster, Antonina, Sanford, Sara E., Sheth, Anandi N., Lennox, Jeffrey L., Knezevic, Andrea, Ward, Laura, Easley, Kirk A., Powers, Philip, Weitzmann, M. Neale
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
HIV/AIDS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4981757/
https://ncbi.nlm.nih.gov/pubmed/27193748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw331
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items